Macular oedema (diabetic) - aflibercept: committee papers
Table of Contents
01 Pre-Meeting Briefing prepared by NICE
02 Submission from the technology manufacturer - BAYER
03 NICE request to the manufacturer for clarification on their submission
04 Manufacturer clarification response
05 Consultee submission - Royal College of Ophthalmologists
05 Diabetes UK, Macular Society and Royal National Institute of Blind People - Joint submission
06 Clinicalexpert personal perspective -Sivaprasad
06 Patient expert personal perspective -Worrall
07 Evidence Review Group report prepared by Aberdeen HTA Group
08 Manufacturer factual accuracy check of Evidence Review Group report
09 Erratum to the Evidence Review Group report
10 Evidence Review Group exploratory analysis
Macular oedema (diabetic) - aflibercept: committee papers
20 February 2015 (10.29 Mb 9 sec) |
This page was last updated: 28 May 2015